Pretransplant and immediate posttransplant care of pediatric kidney transplant patients
Related topics:
Rapid-turnaround preoperative COVID screening should be performed immediately upon arrival
Human leukocyte antigen (HLA) at time of transplant
Coagulation factors: prothrombin time (PT), partial thromboplastin time (PTT)/international normalized ratio (INR)
If a hemodialysis (HD) catheter is in place, culture all lumens of the HD catheter
If on peritoneal dialysis (PD), collect dialysate fluid cell count, gram stain and culture
After sample is collected, connect PD catheter to drain bag and allow to drain to gravity
Urinalysis (UA) and urine culture if able to collect a urine sample (e.g., not anuric/severely oliguric)
Girls ≥12 years of age:
Urine hCG if able to collect a urine sample (e.g., not anuric/severely oliguric), otherwise blood hCG
Unless precluded by state laws, OPTN policies dictate that for patients ≥12 years of age the following labs must be sent after admission but before anastomosis of the graft:
HIV using a CDC recommended laboratory HIV testing algorithm
Hepatitis B virus (HBV): [PDF: CDC interpretation guide]
HBcAb: hepatitis B core antibody (total, IgG + IgM),
HBsAb: hepatitis B surface antibody (quantitative), and
HBsAg: hepatitis B surface antigen
Anti-HCV antibody (IgG)
HCV ribonucleic acid (RNA) by nucleic acid test (NAT), quantitative
Note: polymerase chain reaction (PCR) is a type of NAT
Patients who are <12 years of age will have these labs drawn as part of their transplant evaluation process or while they are on the waiting list
If on hemodialysis (HD) or peritoneal dialysis (PD), will they require a HD and PD treatment prior to going to the OR?
Ensure that up-to-date information is available regarding their dialysis prescription
Does this patient require intraoperative CKRT?
Induction immunosuppression?
Typically anti-thymocyte globulin, mycophenolate mofetil, and methylprednisolone
For patients who will be going promptly to the OR, mycophenolate mofetil (Cellcept) is generally given intravenously immediately after IV access is established
Is plasmapheresis required?
Do they require a dose of eculizumab?
Maintenance immunosuppression: steroid free or steroid based?
Consent should be obtained by the transplant surgery team
If a donor is classified as high/increased risk, then a "high risk consent" must be obtained from the patient/family by the transplant surgery team
Patients should be made NPO on arrival (and are often instructed to be NPO prior to arrival to the hospital)
Strict I&Os: all intakes and outputs should be closely measured
Careful ongoing assessment of fluid balance is essential to ensure appropriate hydration status before going to the OR
For some patients, this data can be used to determine whether a patient is actively polyuric
Continuous intravenous fluids
If they are dehydrated and require resuscitation, consider a fluid bolus (10-20 mL/kg, up to 1 L) with 0.9% normal saline
D5-NS is often an appropriate choice
If a patient is polyuric, monitor closely to keep their fluid balance net positive
If they have a urinary concentrating defect, D5-0.45% ("half normal") or D5-0.225% ("quarter normal") saline may be a more appropriate fluid choice
If a patient is oliguric/anuric, target a fluid balance that slightly exceeds insensible losses to maintain a gentle positive fluid balance
Estimate insensible losses at 400 mL/m²/day, and divide over 24 hours to get the hourly fluid rate
Discontinue ACE inhibitors
Target blood pressures on the high end of normal (around 90th percentile)
Consider discontinuing other antihypertensives
Patients may need to have one or both of their native kidneys removed at time of transplant:
Uncontrolled kidney-related hypertension
Difficult to control kidney-related hypertension (i.e., requiring ≥3 agents)
Polycystic kidney disease, especially in patients with a history of infected cysts or very large kidneys
Polyuria to a degree that the recipient would have difficulty keeping up enough fluid intake to balance the urine lost from the transplanted kidney and native kidneys
Severe vesicoureteral reflux and megaureter that is not amenable to repair
Recent history of recurrent UTIs
Need for space
The kidney allograft is placed extraperitoneally in the right or left iliac fossa (typically on the right)
The donor renal vessels are usually anastomosed to the external iliac vessels of the recipient, though this may vary
Urinary reconstruction is almost always via uretero-neocystostomy (donor ureter is connected to recipient bladder), although at times other types of reconstruction can be chosen
After anastomosis, the surgery team will be able to note the blood pressure at which the kidney appears well perfused and has robust urine output; this information will be useful in the postoperative period
Initial function of the allograft is enhanced by:
Short cold ischemia time
Short rewarming (anastomosis) time
Intravascular volume repletion
POST-OP INPATIENT MANAGEMENT
Don’t forget basic general surgery: eval for flatulence/bowel sounds/movement
Will have to adjust timing and medications of everything in the order set
Total max goals of IVF POD0 can be up to 500 cc/hr when doing the 1:1 urine replacement
Urine output goals POD0 typically minimum 50 cc/hour
When the urine output starts to drop to less than the 50 cc/hr, the 1:1 replacement of fluids doesn’t provide enough IVF, and should change over to 2.5 L/m2/day of total fluids (most often by POD1)
If needing volume/boluses:
NS @ 10 cc/kg
Consider 5% albumin (Colloid) @ 10 cc/kg
Initial vasopressor of choice: Dopamine
PO options for BP augmentation: 1) Midodrine 2) Fludrocortisone
Diuretics:
Think twice before giving Lasix -- transplanted kidneys are extremely sensitive to diuretics, and require a very low dose
Interpreting CVP waveforms: https://learn.openpediatrics.org/learn/course/internal/view/elearning/3115/interpreting-central-venous-pressure-waveforms
[AMA formatted citations]
***